Rarity Bioscience
Hanna Kocken has extensive work experience in the quality and regulatory field. Hanna currently holds the position of Director of Quality and Regulatory at Rarity Bioscience. Prior to that, they worked at Thermo Fisher Scientific, where they held various roles, including Senior Manager of System R&D and Acting Director of Global RA IDD Phadia. Before Thermo Fisher Scientific, they worked at ÅF AB as a Consultant. Hanna'searly career includes a role as a Technical Product Manager at Bactiguard AB.
Hanna Kocken attended the KTH Royal Institute of Technology but no specific degree, field of study, start year, or end year was provided.
This person is not in any teams
This person is not in any offices
Rarity Bioscience
Rarity Bioscience provides ultrasensitive multiplex assays for mutation detecting in blood and other liquid biopsies for research, pharma and clinics. The sensitivity of our precision diagnostics technology enables patient stratification, treatment choice & monitoring, early MRD and relapse detection and post-transplantation follow-up for optimized cancer care. It also enables refined inclusion stratification and monitoring in clinical trials. The company was founded 2021 based on a discovery by Dr Lei Chen, PhD in molecular biology and a member of Professor Ulf Landegrens team at the Department of Immunology, Genomics and Pathology at Uppsala University.